CAAS Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-3,900
| Closed | -$112K | – | 291 |
|
|
2023
Q4 | $112K | Buy |
+3,900
| New | +$112K | 0.01% | 89 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 417 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 484 |
|
|
2022
Q3 | – | Sell |
-18,900
| Closed | -$991K | – | 596 |
|
|
2022
Q2 | $991K | Buy |
+18,900
| New | +$991K | 0.05% | 129 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 554 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 640 |
|
|
2021
Q3 | – | Sell |
-18,500
| Closed | -$724K | – | 751 |
|
|
2021
Q2 | $724K | Buy |
+18,500
| New | +$724K | 0.01% | 361 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 580 |
|
|
2020
Q3 | – | Sell |
-2,319
| Closed | -$72K | – | 380 |
|
|
2020
Q2 | $72K | Buy |
+2,319
| New | +$72K | ﹤0.01% | 173 |
|